News | July 22, 2013

Elekta Receives CE Marking for Clarity 4-D Monitoring

Soft tissue visualization system addresses organ motion challenges during prostate cancer radiotherapy

July 22, 2013 — Elekta has received CE marking for its Clarity 4-D monitoring system, permitting European clinics to implement this new way of reducing the uncertainty caused by prostate motion during radiation treatment. Physicians will be able to monitor the motion of the prostate with sub-millimeter accuracy during the delivery of therapeutic radiation beams.

The ability to continuously visualize the prostate and surrounding anatomy during treatment is especially important for clinicians pursuing advanced prostate protocols, such as reduced margin hypofractionated therapy or advanced stereotactic ablative body radiotherapy (SABR).

Continuous target visualization

Four-dimensional monitoring of the prostate with Clarity during treatment offers continuous tracking of the target and imaging of the surrounding anatomy, including the bladder, rectum and penile bulb. Clinicians are keen to avoid this surrounding anatomy to minimize the chance of side effects of treatment such as erectile dysfunction, incontinence or rectal bleeding. Being able to visualize these structures during treatment could potentially enable clinicians to create plans with tighter margins around intended targets, thereby minimizing radiation exposure to healthy tissue.

Clarity 4-D monitoring uses Autoscan acquisition technology to robotically acquire live transperineal ultrasound images of soft tissue anatomy. The noninvasive imaging procedure does not involve any extra radiation dose to the patient and does not require the use of implanted markers.

Cancer patients at Hopital Riviera in Vevey, Switzerland, will soon benefit from the custom technology configuration of their newly acquired Versa HD radiotherapy system and Clarity 4-D monitoring system.

"We are committed to offering the most advanced technologies to our patients, which is why we chose Elekta's Versa HD solution, including Clarity 4-D monitoring for prostate. We will use this system for transperineal imaging of the prostate to align the daily treatment with the prostate's position and eventually monitor that position during treatment. This represents a substantial step forward in treating patients and we look forward to using the technology," says Oscar Matzinger, M.D., radiation oncologist at Hopital Riviera and Centre Hospitalier Universitaire Vaudois (Lausanne, Switzerland).

Physicians at Torino, Italy's University Hospital of Turin also are looking forward to improving prostate tracking with Clarity 4-D monitoring.

"Intrafractional motion management will continue to increase in importance as more sophisticated methods of treating the prostate gain acceptance," says Umberto Ricardi, M.D., radiation oncologist at the center. "Clarity 4-D monitoring will be an important component in realizing the potential these protocols offer us as clinicians." 

For more information: www.elekta.com/clarity

Related Content

SpaceOAR Hydrogel Now Available in Japan
News | Patient Positioning Radiation Therapy | July 16, 2018
Augmenix K.K. announced that SpaceOAR hydrogel, a soft, implanted absorbable gel spacer is now available to all...
RaySearch Releases New Version of RayCare OIS
Technology | Oncology Information Management Systems (OIMS) | July 13, 2018
RaySearch has released RayCare 2A, the latest version of its flagship oncology information system (OIS). RayCare is...
Lack of Insurance Coverage Delaying Proton Therapy Clinical Trials
News | Proton Therapy | July 12, 2018
Randomized clinical trials are the gold standard of cancer research and can shed light on whether innovative, new...
Bruce Power Joins Forces With ITM to Supply Lutetium-177 for Cancer Therapy
News | Radiation Therapy | July 11, 2018
Canadian nuclear power company Bruce Power and German-based Isotope Technologies Garching (ITG) signed an agreement to...
MedStar Georgetown University Hospital Now Clinical With RayStation and Hyperscan
News | Treatment Planning | July 05, 2018
MedStar Georgetown University Hospital in Washington D.C., has begun patient treatments using the RayStation treatment...
Northern Centre for Cancer Care (NCCC)

Northern Centre for Cancer Care (NCCC).

Sponsored Content | Case Study | Radiation Therapy | July 05, 2018
Established in 2009, Northern Centre for Cancer Care (NCCC) is the largest center of its kind in the north of England....
Researcher Investigates Eliminating Radiation for HER2-Positive Breast Cancer
News | Radiation Therapy | July 02, 2018
Researchers at The University of Kansas Cancer Center have launched a clinical trial that eliminates radiation from the...
New Prostate Cancer Radiotherapy Technique Aims to Preserve Sexual Function
News | Radiation Therapy | June 18, 2018
A multicenter clinical trial being led by UT Southwestern physicians is testing a technique for sparing nerve bundles...
Elekta Unity High-Field MR-Linac Receives CE Mark
News | Image Guided Radiation Therapy (IGRT) | June 18, 2018
Elekta announced that its Elekta Unity magnetic resonance radiation therapy (MR/RT) system has received CE mark,...
Washington University in St. Louis Begins Clinical Treatments With ViewRay MRIdian Linac
News | Image Guided Radiation Therapy (IGRT) | June 14, 2018
June 14, 2018 — The Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in S
Overlay Init